JP2003002827A5 - - Google Patents

Download PDF

Info

Publication number
JP2003002827A5
JP2003002827A5 JP2001186681A JP2001186681A JP2003002827A5 JP 2003002827 A5 JP2003002827 A5 JP 2003002827A5 JP 2001186681 A JP2001186681 A JP 2001186681A JP 2001186681 A JP2001186681 A JP 2001186681A JP 2003002827 A5 JP2003002827 A5 JP 2003002827A5
Authority
JP
Japan
Prior art keywords
formula
ameliorating
agent according
agent
tetrahydrocurcumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2001186681A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003002827A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001186681A priority Critical patent/JP2003002827A/ja
Priority claimed from JP2001186681A external-priority patent/JP2003002827A/ja
Publication of JP2003002827A publication Critical patent/JP2003002827A/ja
Publication of JP2003002827A5 publication Critical patent/JP2003002827A5/ja
Ceased legal-status Critical Current

Links

JP2001186681A 2001-06-20 2001-06-20 血中中性脂肪の増加の予防又は改善剤 Ceased JP2003002827A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001186681A JP2003002827A (ja) 2001-06-20 2001-06-20 血中中性脂肪の増加の予防又は改善剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001186681A JP2003002827A (ja) 2001-06-20 2001-06-20 血中中性脂肪の増加の予防又は改善剤

Publications (2)

Publication Number Publication Date
JP2003002827A JP2003002827A (ja) 2003-01-08
JP2003002827A5 true JP2003002827A5 (enExample) 2008-06-26

Family

ID=19026094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001186681A Ceased JP2003002827A (ja) 2001-06-20 2001-06-20 血中中性脂肪の増加の予防又は改善剤

Country Status (1)

Country Link
JP (1) JP2003002827A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007320864A (ja) * 2006-05-30 2007-12-13 Toshihiko Osawa 非アルコール性脂肪肝炎予防・治療用組成物
JP5292569B2 (ja) * 2006-11-10 2013-09-18 国立大学法人名古屋大学 抗老化転写因子活性化剤及びその利用
WO2009025315A1 (ja) * 2007-08-21 2009-02-26 Kyowa Hakko Bio Co., Ltd. クルクミン類のバイオアベイラビリティ向上用経口剤
JP5829064B2 (ja) * 2011-07-06 2015-12-09 サッポロビール株式会社 発泡性飲料及びその製造方法並びに泡特性向上剤及び泡特性向上方法
CN112638399B (zh) * 2018-08-31 2022-12-30 好侍健康食品株式会社 含有源自姜黄的成分、在口腔内咀嚼和/或在口腔内溶解的口服组合物
CN114728876A (zh) * 2019-10-15 2022-07-08 萨米-萨宾莎集团有限公司 姜黄素类组合物及其处理肺纤维化的治疗潜力
CN116369434A (zh) * 2023-05-09 2023-07-04 南京农业大学 四氢姜黄素作为减少畜禽脂肪沉积和降低畜禽背膘厚度的饲料添加剂的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4114992B2 (ja) * 1998-02-24 2008-07-09 協和醗酵工業株式会社 テトラヒドロクルクミン類の製造方法

Similar Documents

Publication Publication Date Title
JP4445590B2 (ja) パロキセチン−レジン含有の経口液体組成物
WO2004012700A3 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
JPH11509223A5 (enExample)
AP2001002288A0 (en) Methods for treatment of sickle cell anemia.
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2002020466B1 (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CA2386690A1 (en) Pharmaceutical tramadol salts
JP2005515966A (ja) 鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
EP1537859A3 (en) Azithromycin dosage forms with reduced side effects
CA2382480A1 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
WO2002045686A3 (en) Pharmaceutical paste comprising an acid-labile active ingredient
JP2003506416A5 (enExample)
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
RU2003100507A (ru) Фармацевтические композиции
CA2389032A1 (en) Preventive or therapeutic agents for inflammatory diseases of intestine
JP2004510816A5 (enExample)
JP2003002827A5 (enExample)
JPH10147529A5 (enExample)
EP1284265A4 (en) BENZOTHIOPHENE DERIVATIVES AND MEDICINAL USE THEREOF
JP2003514025A5 (enExample)
JP2002515439A5 (enExample)
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
CA2438506A1 (en) Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
WO2002080981A3 (en) Polynucleotide binding complexes comprising sterols and saponins